Bufalin Targets CENPA-modulated Glycolysis via PI3K/AKT in Hepatocellular Carcinoma: A Bioinformatics, In Vitro and Preliminary In Vivo Evidence.
Findings suggest that bufalin may suppress CENPA-associated glycolysis and HCC cell migration through modulation of PI3K/AKT signaling.